ReShape Lifesciences Inc. (RSLS) will report its next earnings on Aug 14 AMC. The company reported the earnings of $-4.8/Share in the last quarter where the estimated EPS by analysts was $-1.79/share. The difference between the expected and actual EPS was $-3.01/share, which represents an Earnings surprise of -168.2%.
Many analysts are providing their Estimated Earnings analysis for ReShape Lifesciences Inc. and for the current quarter 1 analysts have projected that the stock could give an Average Earnings estimate of $-1.47/share. These analysts have also projected a Low Estimate of $-1.47/share and a High Estimate of $-1.47/share.
In case of Revenue Estimates, 1 analysts have provided their consensus Average Revenue Estimates for ReShape Lifesciences Inc. as 1.24 Million. According to these analysts, the Low Revenue Estimate for ReShape Lifesciences Inc. is 1.24 Million and the High Revenue Estimate is 1.24 Million. The company had Year Ago Sales of 360 Million.
Some buy side analysts are also providing their Analysis on ReShape Lifesciences Inc., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)
When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for ReShape Lifesciences Inc. might touch $32 high while the Average Price Target and Low price Target is $32 and $32 respectively.
The Relative Volume of the company is 1.72 and Average Volume (3 months) is 3.34 million.
The company shows its Return on Assets (ROA) value of -56.9%. The Return on Equity (ROE) value stands at -65.2%. While it’s Return on Investment (ROI) value is -41.1%.
While looking at the Stock’s Performance, ReShape Lifesciences Inc. currently shows a Weekly Performance of 9.72%, where Monthly Performance is -94.4%, Quarterly performance is -98.67%, 6 Months performance is -99.63% and yearly performance percentage is -99.73%. Year to Date performance value (YTD perf) value is -99.64%. The Stock currently has a Weekly Volatility of 168.70% and Monthly Volatility of 51.28%.